Dasatinib Zentiva 70 mg filmom obložene tablete Kroatien - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

dasatinib zentiva 70 mg filmom obložene tablete

zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - дазатиниб - filmom obložena tableta - 70 mg - urbroj: jedna filmom obložena tableta sadrži 70 mg dasatiniba

Nodriga 100 mg filmom obložene tablete Kroatien - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

nodriga 100 mg filmom obložene tablete

alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 100 mg dasatiniba

Nodriga 140 mg filmom obložene tablete Kroatien - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

nodriga 140 mg filmom obložene tablete

alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 140 mg dasatiniba

Nodriga 20 mg filmom obložene tablete Kroatien - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

nodriga 20 mg filmom obložene tablete

alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 20 mg dasatiniba

Nodriga 50 mg filmom obložene tablete Kroatien - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

nodriga 50 mg filmom obložene tablete

alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 50 mg dasatiniba

Nodriga 70 mg filmom obložene tablete Kroatien - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

nodriga 70 mg filmom obložene tablete

alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 70 mg dasatiniba

Dasatinib Accord Den Europæiske Union - kroatisk - EMA (European Medicines Agency)

dasatinib accord

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.

Dasatinib Accordpharma Den Europæiske Union - kroatisk - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.